Medical devices, healthcare technology and the business of care
510(k) clearance · K260283

VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL)

BIOMERIEUX, Inc. · Decision date Oct 1, 2026

MEDTECHLEDGER EXPLANATIONK260283

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-01 for K260283, submitted by bioMerieux, Inc. of Hazelwood, Missouri. The device is listed as VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL), an automated short-incubation antimicrobial susceptibility test system under regulation 866.1645, product code LON, in the microbiology specialty. The application was received 01/29/2026 and reviewed as a traditional 510(k) by FDA rather than a third party.

SESE in this 510(k) context denotes clearance of the submission, not premarket approval of a new device. The record states that a Predetermined Change Control Plan was authorized and that the submission was not a combination product. The public record does not include the decision summary text, performance data, or the specific modifications described in the authorized change control plan, so the scope of what was cleared beyond the listed device name and range cannot be determined from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Microbiology
Decision date
Oct 1, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260283
Regulatory pathway
510(k) premarket notification
Product code
LON
Decision code
SESE
Decision date
Oct 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation.

Product code
LON
FDA device class
2

FDA decision timeline

  1. K260283 received

    Application receipt date recorded by FDA.

  2. K260283 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LON

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

BIOMERIEUX, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hazelwood, MO

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records